1 year return (CAGR)
19.33%
NLS Pharmaceutics AG Exchange (NASDAQ, USD)
NLSPW
-
-0.00 (-3.24%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
0.00
Price/Sales
-
Ent value
9.91M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-8.08%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.02 |
| Daily high | 0.02 |
| Daily low | 0.01 |
| Daily Volume | 130K |
| 1y analyst estimate | - |
| Beta | 0.13 |
| EPS (TTM) | -5.41 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NLSPW | S&P500 | |
| Current price drop from All-time high | -99.03% | -1.80% |
| Highest price drop | -99.89% | -56.47% |
| Date of highest drop | 9 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -99.25% | -10.68% |
| Avg time to new high | - | 12 days |
| Max time to new high | 266 days | 1805 days |
News
No items found